Logo image of EXE.PA

EXEL INDUSTRIES SA-A SHS (EXE.PA) Stock Fundamental Analysis

Europe - EPA:EXE - FR0004527638 - Common Stock

37.9 EUR
-0.5 (-1.3%)
Last: 9/16/2025, 1:12:47 PM
Fundamental Rating

5

Overall EXE gets a fundamental rating of 5 out of 10. We evaluated EXE against 103 industry peers in the Machinery industry. EXE has only an average score on both its financial health and profitability. EXE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year EXE was profitable.
EXE had a positive operating cash flow in the past year.
EXE had positive earnings in 4 of the past 5 years.
Of the past 5 years EXE 4 years had a positive operating cash flow.
EXE.PA Yearly Net Income VS EBIT VS OCF VS FCFEXE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

EXE's Return On Assets of 3.51% is in line compared to the rest of the industry. EXE outperforms 56.31% of its industry peers.
EXE has a Return On Equity of 6.73%. This is comparable to the rest of the industry: EXE outperforms 48.54% of its industry peers.
EXE has a better Return On Invested Capital (6.89%) than 62.14% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXE is below the industry average of 8.77%.
The last Return On Invested Capital (6.89%) for EXE is above the 3 year average (6.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.51%
ROE 6.73%
ROIC 6.89%
ROA(3y)3.83%
ROA(5y)3.13%
ROE(3y)7.71%
ROE(5y)6.23%
ROIC(3y)6.68%
ROIC(5y)6.61%
EXE.PA Yearly ROA, ROE, ROICEXE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

EXE's Profit Margin of 2.83% is in line compared to the rest of the industry. EXE outperforms 47.57% of its industry peers.
In the last couple of years the Profit Margin of EXE has grown nicely.
The Operating Margin of EXE (5.13%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of EXE has grown nicely.
EXE has a better Gross Margin (47.00%) than 62.14% of its industry peers.
EXE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.13%
PM (TTM) 2.83%
GM 47%
OM growth 3Y-6.28%
OM growth 5Y4%
PM growth 3Y-17.01%
PM growth 5Y39.98%
GM growth 3Y-0.94%
GM growth 5Y7.12%
EXE.PA Yearly Profit, Operating, Gross MarginsEXE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EXE is creating some value.
The number of shares outstanding for EXE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, EXE has about the same amount of shares outstanding.
The debt/assets ratio for EXE has been reduced compared to a year ago.
EXE.PA Yearly Shares OutstandingEXE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
EXE.PA Yearly Total Debt VS Total AssetsEXE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.85 indicates that EXE is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXE has a Altman-Z score of 2.85. This is in the better half of the industry: EXE outperforms 67.96% of its industry peers.
The Debt to FCF ratio of EXE is 9.26, which is on the high side as it means it would take EXE, 9.26 years of fcf income to pay off all of its debts.
EXE has a worse Debt to FCF ratio (9.26) than 63.11% of its industry peers.
EXE has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.16, EXE is in the better half of the industry, outperforming 73.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 9.26
Altman-Z 2.85
ROIC/WACC1.05
WACC6.55%
EXE.PA Yearly LT Debt VS Equity VS FCFEXE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.75 indicates that EXE should not have too much problems paying its short term obligations.
EXE has a Current ratio of 1.75. This is comparable to the rest of the industry: EXE outperforms 59.22% of its industry peers.
EXE has a Quick Ratio of 1.75. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.82, EXE is doing worse than 63.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.82
EXE.PA Yearly Current Assets VS Current LiabilitesEXE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

The earnings per share for EXE have decreased strongly by -26.98% in the last year.
Measured over the past years, EXE shows a very strong growth in Earnings Per Share. The EPS has been growing by 50.29% on average per year.
Looking at the last year, EXE shows a small growth in Revenue. The Revenue has grown by 0.46% in the last year.
Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 7.19% on average per year.
EPS 1Y (TTM)-26.98%
EPS 3Y-10.42%
EPS 5Y50.29%
EPS Q2Q%-33.9%
Revenue 1Y (TTM)0.46%
Revenue growth 3Y7.83%
Revenue growth 5Y7.19%
Sales Q2Q%-0.76%

3.2 Future

Based on estimates for the next years, EXE will show a decrease in Earnings Per Share. The EPS will decrease by -1.53% on average per year.
Based on estimates for the next years, EXE will show a decrease in Revenue. The Revenue will decrease by -0.88% on average per year.
EPS Next Y-36.34%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EPS Next 5YN/A
Revenue Next Year-8.38%
Revenue Next 2Y-3.11%
Revenue Next 3Y-0.88%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXE.PA Yearly Revenue VS EstimatesEXE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
EXE.PA Yearly EPS VS EstimatesEXE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.24, the valuation of EXE can be described as reasonable.
Based on the Price/Earnings ratio, EXE is valued cheaper than 90.29% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.27, EXE is valued rather cheaply.
EXE is valuated correctly with a Price/Forward Earnings ratio of 12.68.
Based on the Price/Forward Earnings ratio, EXE is valued a bit cheaper than 64.08% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.77. EXE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 8.24
Fwd PE 12.68
EXE.PA Price Earnings VS Forward Price EarningsEXE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

EXE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EXE is cheaper than 83.50% of the companies in the same industry.
68.93% of the companies in the same industry are more expensive than EXE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.33
EV/EBITDA 4.49
EXE.PA Per share dataEXE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The decent profitability rating of EXE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.04%, EXE has a reasonable but not impressive dividend return.
EXE's Dividend Yield is rather good when compared to the industry average which is at 2.88. EXE pays more dividend than 85.44% of the companies in the same industry.
EXE's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.04%

5.2 History

On average, the dividend of EXE grows each year by 6.63%, which is quite nice.
Dividend Growth(5Y)6.63%
Div Incr Years1
Div Non Decr Years1
EXE.PA Yearly Dividends per shareEXE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

34.22% of the earnings are spent on dividend by EXE. This is a low number and sustainable payout ratio.
DP34.22%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EXE.PA Yearly Income VS Free CF VS DividendEXE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M
EXE.PA Dividend Payout.EXE.PA Dividend Payout, showing the Payout Ratio.EXE.PA Dividend Payout.PayoutRetained Earnings

EXEL INDUSTRIES SA-A SHS

EPA:EXE (9/16/2025, 1:12:47 PM)

37.9

-0.5 (-1.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-23 2025-07-23
Earnings (Next)10-24 2025-10-24
Inst Owners8.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap257.34M
Analysts48.89
Price Target41.48 (9.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.04%
Yearly Dividend1.57
Dividend Growth(5Y)6.63%
DP34.22%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.94%
PT rev (3m)-5.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-45.02%
EPS NY rev (3m)-45.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.13%
Valuation
Industry RankSector Rank
PE 8.24
Fwd PE 12.68
P/S 0.23
P/FCF 13.33
P/OCF 5.19
P/B 0.56
P/tB 0.69
EV/EBITDA 4.49
EPS(TTM)4.6
EY12.14%
EPS(NY)2.99
Fwd EY7.89%
FCF(TTM)2.84
FCFY7.5%
OCF(TTM)7.3
OCFY19.25%
SpS161.9
BVpS68.21
TBVpS54.64
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 3.51%
ROE 6.73%
ROCE 9.89%
ROIC 6.89%
ROICexc 7.56%
ROICexgc 9.18%
OM 5.13%
PM (TTM) 2.83%
GM 47%
FCFM 1.76%
ROA(3y)3.83%
ROA(5y)3.13%
ROE(3y)7.71%
ROE(5y)6.23%
ROIC(3y)6.68%
ROIC(5y)6.61%
ROICexc(3y)7.49%
ROICexc(5y)7.69%
ROICexgc(3y)9.26%
ROICexgc(5y)9.78%
ROCE(3y)9.59%
ROCE(5y)9.66%
ROICexcg growth 3Y-11.14%
ROICexcg growth 5Y6.57%
ROICexc growth 3Y-8.43%
ROICexc growth 5Y6.79%
OM growth 3Y-6.28%
OM growth 5Y4%
PM growth 3Y-17.01%
PM growth 5Y39.98%
GM growth 3Y-0.94%
GM growth 5Y7.12%
F-Score7
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 9.26
Debt/EBITDA 0.87
Cap/Depr 100.15%
Cap/Sales 2.75%
Interest Coverage 6.24
Cash Conversion 57.19%
Profit Quality 61.97%
Current Ratio 1.75
Quick Ratio 0.82
Altman-Z 2.85
F-Score7
WACC6.55%
ROIC/WACC1.05
Cap/Depr(3y)92.15%
Cap/Depr(5y)79.17%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.98%
EPS 3Y-10.42%
EPS 5Y50.29%
EPS Q2Q%-33.9%
EPS Next Y-36.34%
EPS Next 2Y-8.26%
EPS Next 3Y-1.53%
EPS Next 5YN/A
Revenue 1Y (TTM)0.46%
Revenue growth 3Y7.83%
Revenue growth 5Y7.19%
Sales Q2Q%-0.76%
Revenue Next Year-8.38%
Revenue Next 2Y-3.11%
Revenue Next 3Y-0.88%
Revenue Next 5YN/A
EBIT growth 1Y-15.46%
EBIT growth 3Y1.06%
EBIT growth 5Y11.48%
EBIT Next Year51.35%
EBIT Next 3Y18.78%
EBIT Next 5YN/A
FCF growth 1Y-69.03%
FCF growth 3Y-25.63%
FCF growth 5Y-8.04%
OCF growth 1Y-40.05%
OCF growth 3Y-7.67%
OCF growth 5Y4.57%